These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Dosage of Cyclosporin A in children with renal transplants. Hoyer PF; Offner G; Wonigeit K; Brodehl J; Pichlmayr R Clin Nephrol; 1984 Aug; 22(2):68-71. PubMed ID: 6383673 [TBL] [Abstract][Full Text] [Related]
44. Prophylaxis of graft-versus-host disease with cyclosporine-prednisone is associated with increased risk of chronic graft-versus-host disease. Kumar S; Chen MG; Gastineau DA; Gertz MA; Inwards DJ; Lacy MQ; Tefferi A; Harmsen WS; Litzow MR Bone Marrow Transplant; 2001 Jun; 27(11):1133-40. PubMed ID: 11551023 [TBL] [Abstract][Full Text] [Related]
45. The determination of metabolite M17 and its meaning for immunosuppressive cyclosporin therapy. Khoschsorur G; Auer T; Lanzer G; Petritsch P; Holzer H; Tscheliessnigg KH Angiology; 1998 Apr; 49(4):307-14. PubMed ID: 9555934 [TBL] [Abstract][Full Text] [Related]
46. Marrow transplant experience for children with severe aplastic anemia. Sanders JE; Storb R; Anasetti C; Deeg HJ; Doney K; Sullivan KM; Witherspoon RP; Hansen J Am J Pediatr Hematol Oncol; 1994 Feb; 16(1):43-9. PubMed ID: 8311172 [TBL] [Abstract][Full Text] [Related]
47. Renal function and blood pressure in psoriatic patients treated with cyclosporin A. Feutren G; Abeywickrama K; Friend D; von Graffenried B Br J Dermatol; 1990 Jun; 122 Suppl 36():57-69. PubMed ID: 2196085 [TBL] [Abstract][Full Text] [Related]
48. Combination of cyclosporin and methotrexate for prophylaxis of acute graft-versus-host disease after allogeneic bone marrow transplantation for leukemia. Mrsić M; Labar B; Bogdanić V; Nemet D; Pavletić Z; Plavsić F; Dobrić I; Marusić M; Francetić I; Kastelan A Bone Marrow Transplant; 1990 Aug; 6(2):137-41. PubMed ID: 2207450 [TBL] [Abstract][Full Text] [Related]
54. IL-2 inhibits early increases in serum gamma interferon levels associated with graft-versus-host-disease. Szebeni J; Wang MG; Pearson DA; Szot GL; Sykes M Transplantation; 1994 Dec; 58(12):1385-93. PubMed ID: 7809932 [TBL] [Abstract][Full Text] [Related]
55. Increase of interleukin-18 serum levels after engraftment correlates with acute graft-versus-host disease in allogeneic peripheral blood stem cell transplantation. Scholl S; Sayer HG; Mügge LO; Kasper C; Pietraszczyk M; Kliche KO; Clement JH; Höffken K J Cancer Res Clin Oncol; 2004 Dec; 130(12):704-10. PubMed ID: 15365821 [TBL] [Abstract][Full Text] [Related]
56. Single-dose daily infusion of cyclosporine for prevention of Graft-versus-host disease after allogeneic bone marrow transplantation from HLA allele-matched, unrelated donors. Nawa Y; Hara M; Tanimoto K; Nakase K; Kozuka T; Maeda Y Int J Hematol; 2006 Feb; 83(2):159-63. PubMed ID: 16513536 [TBL] [Abstract][Full Text] [Related]
57. [CD25 monoclonal antibody for GVHD prophylaxis in non-T-cell depleted haploidentical bone marrow transplantation for treatment of childhood leukemia]. Chen HR; Ji SQ; Yan HM; Wang HX; Liu J; Xue M; Zhu L Zhonghua Er Ke Za Zhi; 2004 Apr; 42(4):294-8. PubMed ID: 15157394 [TBL] [Abstract][Full Text] [Related]
58. Analysis of side-effects of medium- and low-dose cyclosporin maintenance therapy in psoriasis. de Rie MA; Meinardi MM; Bos JD Br J Dermatol; 1990 Sep; 123(3):347-53. PubMed ID: 2206973 [TBL] [Abstract][Full Text] [Related]
59. FK506 treatment of graft-versus-host disease developing or exacerbating during prophylaxis and therapy with cyclosporin and/or other immunosuppressants. Japanese FK506 BMT Study Group. Kanamaru A; Takemoto Y; Kakishita E; Dohy H; Kodera Y; Moriyama Y; Shibata A; Kasai M; Katoh S; Saitoh H Bone Marrow Transplant; 1995 Jun; 15(6):885-9. PubMed ID: 7581086 [TBL] [Abstract][Full Text] [Related]
60. Renal function in cardiac transplant recipients: retrospective analysis of 133 consecutive patients in a single center. Tinawi M; Miller L; Bastani B Clin Transplant; 1997 Feb; 11(1):1-8. PubMed ID: 9067686 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]